BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND DDX10, HRH-J8, 1662, ENSG00000178105, Q13206
22 results:

  • 1. Family caregivers' perspective of caring for cancer patients during radiotherapy: A qualitative study.
    Dewi LC; Pratiwi IN; Nimah L; Ramoo V
    J Pak Med Assoc; 2023 Feb; 73(Suppl 2)(2):S18-S20. PubMed ID: 37096694
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mortality and Major Adverse Cardiac Events in Patients With breast cancer Receiving Radiotherapy: The First Decade.
    Jacobs JEJ; L'Hoyes W; Lauwens L; Yu YL; Brusselmans M; Weltens C; Voigt JU; Wildiers H; Neven P; Herrmann J; Thijs L; Staessen JA; Janssens S; Van Aelst LNL
    J Am Heart Assoc; 2023 Apr; 12(8):e027855. PubMed ID: 37026536
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Ki67 assessment in invasive luminal breast cancer: a comparative study between different scoring methods.
    Lashen A; Toss MS; Green AR; Mongan NP; Rakha E
    Histopathology; 2022 Dec; 81(6):786-798. PubMed ID: 35997652
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab-paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031).
    Saji S; Ohsumi S; Ito M; Hayashi N; Kobayashi K; Masuda N; Niikura N; Yamashita T; Kiyama K; Hasegawa A; Nakagawa S; Hattori M
    Jpn J Clin Oncol; 2022 Oct; 52(10):1124-1133. PubMed ID: 35750038
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical validity of clinical treatment score 5 (CTS5) for estimating risk of late recurrence in unselected, non-trial patients with early oestrogen receptor-positive breast cancer.
    Richman J; Ring A; Dowsett M; Sestak I
    Breast Cancer Res Treat; 2021 Feb; 186(1):115-123. PubMed ID: 33222093
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.
    Sud A; Torr B; Jones ME; Broggio J; Scott S; Loveday C; Garrett A; Gronthoud F; Nicol DL; Jhanji S; Boyce SA; Williams M; Riboli E; Muller DC; Kipps E; Larkin J; Navani N; Swanton C; Lyratzopoulos G; McFerran E; Lawler M; Houlston R; Turnbull C
    Lancet Oncol; 2020 Aug; 21(8):1035-1044. PubMed ID: 32702311
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Ultrasonic Diagnosis of breast Nodules Using Modified Faster R-CNN.
    Zhang Z; Zhang X; Lin X; Dong L; Zhang S; Zhang X; Sun D; Yuan K
    Ultrason Imaging; 2019 Nov; 41(6):353-367. PubMed ID: 31615352
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Randomized controlled trial of late-course concurrent versus sequential chemoradiotherapy after mastectomy and axillary surgery in locally advanced breast cancer.
    Lu Y; Huang H; Yang H; Chen D
    Medicine (Baltimore); 2017 Oct; 96(41):e8252. PubMed ID: 29019894
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.
    Welsh JL; Hoskin TL; Day CN; Thomas AS; Cogswell JA; Couch FJ; Boughey JC
    Ann Surg Oncol; 2017 Oct; 24(10):3067-3072. PubMed ID: 28766224
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Late Surgical-Site Infection in Immediate Implant-Based breast Reconstruction.
    Sinha I; Pusic AL; Wilkins EG; Hamill JB; Chen X; Kim HM; Guldbrandsen G; Chun YS
    Plast Reconstr Surg; 2017 Jan; 139(1):20-28. PubMed ID: 28027221
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population.
    Hossain A; Murshid GMM; Zilani MNH; Islam F; Sultana R; Sultana T; Hossain MG; Rahman MM
    Breast Cancer; 2017 Jul; 24(4):571-578. PubMed ID: 27837441
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Gene rearrangements in hormone receptor negative breast cancers revealed by mate pair sequencing.
    Jiao X; Hooper SD; Djureinovic T; Larsson C; Wärnberg F; Tellgren-Roth C; Botling J; Sjöblom T
    BMC Genomics; 2013 Mar; 14():165. PubMed ID: 23496902
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.
    Paterson AH; Anderson SJ; Lembersky BC; Fehrenbacher L; Falkson CI; King KM; Weir LM; Brufsky AM; Dakhil S; Lad T; Baez-Diaz L; Gralow JR; Robidoux A; Perez EA; Zheng P; Geyer CE; Swain SM; Costantino JP; Mamounas EP; Wolmark N
    Lancet Oncol; 2012 Jul; 13(7):734-42. PubMed ID: 22704583
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Transaxillary subpectoral augmentation mammaplasty: a single surgeon's 20-year experience.
    Huang GJ; Wichmann JL; Mills DC
    Aesthet Surg J; 2011 Sep; 31(7):781-801. PubMed ID: 21908810
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patients.
    Chiu CG; Masoudi H; Leung S; Voduc DK; Gilks B; Huntsman DG; Wiseman SM
    Ann Surg; 2010 Jun; 251(6):1107-16. PubMed ID: 20485140
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Galactography: an application of the Galactogram Imaging Classification System (GICS).
    Berná-Serna JD; Torres-Alés C; Berná-Mestre JD; Sola-Pérez J; Canteras-Jordana M
    Acta Radiol; 2010 Mar; 51(2):128-36. PubMed ID: 20001473
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients.
    Lin Y; Yin W; Yan T; Zhou L; Di G; Wu J; Shen Z; Shao Z; Lu J
    BMC Cancer; 2009 Sep; 9():342. PubMed ID: 19778431
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Studies on human breast cancer tissues with Raman microspectroscopy].
    Yu G; Xu XX; Niu Y; Wang B; Song ZF; Zhang CP
    Guang Pu Xue Yu Guang Pu Fen Xi; 2004 Nov; 24(11):1359-62. PubMed ID: 15762476
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. How to perform a comprehensive search for FDG-PET literature.
    Mijnhout GS; Hooft L; van Tulder MW; Devillé WL; Teule GJ; Hoekstra OS
    Eur J Nucl Med; 2000 Jan; 27(1):91-7. PubMed ID: 10654153
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. BRCA1 IVS16+6T-->C is a deleterious mutation that creates an aberrant transcript by activating a cryptic splice donor site.
    Scholl T; Pyne MT; Russo D; Ward BE
    Am J Med Genet; 1999 Jul; 85(2):113-6. PubMed ID: 10406662
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.